Claims for Patent: 7,912,538

Summary for Patent: 7,912,538

Title:	Controlled release transdermal drug delivery
Abstract:	Provided herein is a device for controlling the release of a substance at a site of interest in a biological membrane comprising a means of monitoring a physiological state at the site of interest; and a means of releasing a variable amount of the substance to the site of interest where the amount varies in response to the status of the monitored physiological state. Also provided are methods of using the device.
Inventor(s):	Marchitto; Kevin S. (Golden, CO), Flock; Stephen T (Arvada, CO)
Assignee:	Rocky Mountain Biosystems, Inc (Golden, CO)
Application Number:	12/655,938
Patent Claims:	1. A device for controlling the release of a substance at a site of interest on a biological membrane comprising: means for ablating or altering the biological membrane at the site of interest, wherein said means comprises a mechanical energy delivery system; means of monitoring permeability state of said membrane at the site of interest; means of releasing a variable amount of the substance to the site of interest; said amount varying in response to the status of the monitored permeability state; and means for housing the device. 2. The device of claim 1, wherein the means to monitor the permeability state comprises: at least one first active electrode comprising an anode in electrical contact at the site of interest; a second return electrode comprising a cathode in elettrical contact distal to the first electrode at the site of interest; an optional electrically conductive fluid interface between the first and second electrodes and the site of interest on the biological membrane; and a controller to monitor an electrical current between the first electrode and the second electrode, said controller further comprising a microprocessor. 3. The device of claim 2, wherein the first electrode(s) and the second electrode comprise a galvanic cell. 4. The device of claim 1, wherein the means to monitor the permeability state comprises: at least one probe further comprising an electrical sensor, a chemical sensor or a mechanical sensor, said sensor located at the tip of the probe(s) and the sensor in contact with the site of interest; and a controller to monitor the probe(s), said controller further comprising a microprocessor. 5. The device of claim 1, wherein the means of releasing the variable amount of the substance comprises: a patch comprising: a reservoir to contain the substance; and a release mechanism located between the reservoir and the site of Interest; said mechanism operably connected to a controller; wherein operation of the mechanism by the controller releases the substance from the reservoir to the site of interest or collects the substance in the reservoir from the site of interest. 6. The device of claim 5, further comprising a permeable membrane located between the release mechanism and the site of interest, wherein the permeable membrane is in contact with the site of interest or in contact with a fluid at the site of interest. 7. The device of claim 5, wherein the release mechanism is a valve, a membrane or an electronic pump device. 8. The device of claim 7, wherein the electronic pump device is an electrophoretic device. 9. The device of claim 1, wherein the biological membrane is the skin. 10. The device of claim 9, wherein the skin has an ablated or altered stratum corneum at the site of interest. 11. The device of claim 1, wherein the permeability state comprises an electrical property or a chemical property of the site of interest. 12. The device of claim 11, wherein the electrical property is impedance, conductivity or resistance. 13. The device of claim 11, wherein the chemical property is one or more ion levels at the site of interest. 14. The device of claim 13, wherein the chemical property is the level of lipids, proteins or carbohydrates at the site of interest compound. 15. The device of claim 1, wherein the substance is a pharmaceutical. 16. The device of claim 15, wherein the pharmaceutical compound is nitroglycerin, an anti-nauseant, an antibiotic, a hormone, a steroidal antinflammatory agent, a non-steroid antiinflammatory agent, a chemotherapeutic agent, an anti-cancer agent, an immunogen, an anti-viral agent or an anti-fungal agent. 17. The device of claim 16, wherein the anti-nauseant is scopolamine. 18. The device of claim 16, wherein the antibiotic is tetracycline, streptomycin, sulfa drugs, kanamycin, neomycin, penicillin, or chloramphenicol. 19. The device of claim 16, wherein the hormone is LHRH, parathyroid hormone, growth hormone, gonadotropins, insulin, ACTH, somatostatin, prolactin, placental lactogen, melanocyte stimulating hormone, thyrotropin, parathyroid hormone, calcitonin, enkephalin, or angiotensin. 20. The device of claim 1, wherein the substance is a diagnostic material. 21. A method to control the release of a substance at a site of interest in a biological membrane comprising the steps of: contacting the site of interest with the device of claim 1; ablating or altering the biological membrane using mechanical energy at the site of interest; monitoring permeability state of said membrane at the site of interest; applying an algorithm to evaluate the permeability state; operating a release mechanism in the device of claim 1 in response to the value obtained for the permeability state; and releasing the substance to the site of interest or collecting the substance from the site of interest thereby controlling the release of the substance at the site of interest. 22. The method of claim 21, wherein the value obtained for the permeability state is compared to a control value of the permeability state. 23. The method of claim 22, wherein the control value of the permeability state is obtained from the same individual or within a group of individuals.

Details for Patent 7,912,538

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Nps Pharmaceuticals, Inc.	NATPARA	parathyroid hormone	For Injection	125511	01/23/2015		2022-04-29